Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/13/2007US7294649 Methamphetamine derivatives and conjugates for immunoassay
11/13/2007US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294646 Indole diterpene natural product and synthetic compound; Potassium channel blockers or a formulation thereof in the treatment of glaucoma and other conditions related to elevated intraocular pressure in the eye
11/13/2007US7294645 E.g., N-[[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]butane-1-sulfonamide and 3-chloro-N-[[5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl]methyl]benzenesulfonamide; cannabinoid receptor antagonists
11/13/2007US7294644 CB 1 receptor inverse agonists
11/13/2007US7294643 UK-1 analogues: methods of preparation and use
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294641 Heterocyclic compound for stimulating or inducing the growth of the hair or eyelashes and/or slowing down their loss, composition comprising it and its uses
11/13/2007US7294640 kINESIN SPINDLE PROTEIN INHIBITOR; ANTIPROLIFERATIVE AGENTS; ANTICANCER AGENTS; 4-(2,5-DIFLUORPHENYL)-N-3-FLUOROPYRROLIDIN-3-YL)-2-HYDROXYMETHYL-2-PHENYL-2,5 -DIHYDROXY-1N-PYRROL-1-CARBOXAMIDE
11/13/2007US7294639 E.g., 3-(3'-{[(1-biphenyl-4-ylmethanoyl)methyl-amino]methyl}biphenyl-4-yl)-2-ethoxypropionic acid and 2-ethoxy-3-(3'-{[methyl-(6-oxo-6-phenylhexanoyl)amino]methyl}biphenyl-4-yl)propionic acid; regulating and/or restoring skin lipid metabolism; treating a wide variety of skin disorders
11/13/2007US7294638 Treatment of ADHD
11/13/2007US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007US7294636 Chemical compounds
11/13/2007US7294635 Substituted isoquinolinones
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294633 Oxazolo-and furopyrimidines and their use in medicaments against tumors
11/13/2007US7294632 E.g., 1'-[(2S)-2-Hydroxy-2-phenylethyl]-8'-pyridin-4-yl-3',4'-dihydrospiro[cyclopropane-1,2'-pyrimido[1,2-a]pyrimidin]-6'(1'H)-one; treating non-insulin dependent diabetes
11/13/2007US7294631 Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives
11/13/2007US7294630 Piperazinyl piperidine tachykinin antagonists
11/13/2007US7294629 Drugs as enzyme inhibitors for tyrosine kinases and for treatment of psoriasis
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294627 Factor Xa inhibitors, useful in therapy of thrombotic disorders
11/13/2007US7294626 4-(6-(p-substituted phenyl)-3-pyridazinyl)-1-isopropylpiperazines, e.g., 4-[6-(4-Isopropylpiperazin-1-yl)-pyridazin-3-yl]benzonitrile; treatment of diseases or disorders related to the histamine H3 receptor, e.g., obesity, eating disorders, osteoarthritis, type 2 diabetes, allergic rhinitis, & narcolepsy
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294623 Benzyl morpholine derivatives
11/13/2007US7294622 Lactams and uses thereof
11/13/2007US7294621 Lipid analogs for combating tumors
11/13/2007US7294620 Lipid analogs for inhibiting HIV-1 activity
11/13/2007US7294619 Treating hepatitis B viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294505 Stable episomal vectors
11/13/2007US7294496 Cloned human lysophospholipase
11/13/2007US7294476 Testing a compound for the ability to inhibit PKG I alpha; testing the compound for the ability to inhibit PKG I beta; identifying the compound as a candidate drug useful in the treatment of pain ifit selectively inhibits PKG I alpha relative to PKG I beta .
11/13/2007US7294455 Fixed-dried platelets cross-linked to protein
11/13/2007US7294353 Methods and compositions comprising ilex
11/13/2007US7294350 Healing powder and method of use thereof
11/13/2007US7294349 Wrinkle cream
11/13/2007US7294344 Mixture of angiotensin antagonist and biodegradable polymer; desolventizing; hypotensive agents, cardiovascular disorders
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007US7294330 β-glucuronidase inhibitors for use in deodorants and antiperspirants
11/13/2007CA2480004C Process for production of steroid crystals, crystals obtained thereby and their use in pharmaceutical preparations
11/13/2007CA2473202C Pharmaceutical composition for regeneration of cirrhotic liver
11/13/2007CA2442483C 3-heterocyclylpropanohydroxamic acid pcp inhibitors
11/13/2007CA2431586C Antibiotic/benzoyl peroxide dispenser
11/13/2007CA2425557C Anticholinergic agents that can be used as medicaments and method for the production thereof
11/13/2007CA2423288C New pharmaceutical compositions containing epinastine and pseudoephedrine
11/13/2007CA2420056C 1-amino-alkylcyclohexanes as trypanocidal agents
11/13/2007CA2402707C Use of cdp-choline for the treatment of alcohol withdrawal syndrome
11/13/2007CA2396159C Novel substituted benzimidazole dosage forms and method of using same
11/13/2007CA2383715C Improving condition of elderly pets
11/13/2007CA2362968C Fat based food products
11/13/2007CA2352544C Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2342804C Vending machine
11/13/2007CA2327328C Quinolonecarboxylic acid derivatives or salts thereof
11/13/2007CA2304272C Polymeric microporous film coated subcutaneous implants
11/13/2007CA2301132C Rapidly disintegrating methylcellulose tablets
11/13/2007CA2292965C Pyrrolidine derivative hair growth compositions and uses
11/13/2007CA2289013C Chemical process for the reduction of 1-substituted-3-hydroxymethyl-4-(4-fluorophenyl)tetrahydropyridines
11/13/2007CA2285574C Method and composition for treating sleep apnea
11/13/2007CA2278422C D-methadone, a nonopioid analgesic
11/13/2007CA2253257C Receptor for underivatized, aqueous soluble .beta.(1-3)-glucan
11/13/2007CA2250501C 8-aminoquinolines
11/13/2007CA2231052C Benzoxazepine compounds, their production and use as lipid lowering agents
11/13/2007CA2222680C Endoparasiticidal agents
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2209904C Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
11/13/2007CA2190515C Vaccine against mycobacterial infections
11/13/2007CA2169451C Biochemically balanced peritoneal dialysis solutions
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/13/2007CA2157856C Fluoroalkyl/alkenyl-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/13/2007CA2152137C Phenyl-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them
11/12/2007WO2007132785A1 Agent for preventing organ adhesion and method for preventing adhesion using the same
11/12/2007CA2652322A1 Organ-adhesion preventing agent and process for preventing adhesion using thereof
11/12/2007CA2550397A1 Novel cholesterol-lowering baked food products
11/08/2007WO2007127952A2 Systems and methods for providing non-fully-transparent markets
11/08/2007WO2007127930A2 Compounds affecting gap junction activity
11/08/2007WO2007127908A2 Dihydrobenzoquinone compounds
11/08/2007WO2007127901A1 Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127867A2 Chromium complexes
11/08/2007WO2007127844A2 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
11/08/2007WO2007127810A2 Electrostatic loudspeaker and method of acoustic waves generation
11/08/2007WO2007127787A2 Insulin autoantigen-specific regulatory cd4+ t cells
11/08/2007WO2007127765A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127763A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127731A1 4-squarylpiperazine derivatives as antiviral agents
11/08/2007WO2007127726A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127711A2 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007WO2007127704A1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127693A1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127688A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007WO2007127667A1 Augmentation of titer for vaccination in animals
11/08/2007WO2007127635A2 Diketo-piperazine and piperidine derivatives as antiviral agents
11/08/2007WO2007127624A1 Reducing cancer cell invasion using an inhibitor of toll like receptor signaling
11/08/2007WO2007127569A2 Topical preparation dispensers and methods of using the same
11/08/2007WO2007127524A2 Mutations and polymorphisms of insr
11/08/2007WO2007127505A2 Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
1 ... 3507 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 3526 3527 ... 7860